Skip to Content

Join the 'Topiramate' group to help and get support from people like you.

Topiramate News

Epilepsy Drug, Topiramate, Could Raise Birth Defect Risks

Posted 29 Dec 2017 by Drugs.com

WEDNESDAY, Dec. 27, 2017 – A common anti-seizure drug may pose a birth defect problem for pregnant women, a new study warns. Researchers found that pregnant women with epilepsy who take the drug topiramate during their first trimester may boost the risk that their child will be born with a cleft lip or cleft palate. That risk increase specifically applies to women with epilepsy, who typically ...

Many Migraine Sufferers Given Unecessary Opioids, Study Finds

Posted 25 Aug 2017 by Drugs.com

FRIDAY, Aug. 25, 2017 – Too many people with migraines are prescribed potentially addictive opiate painkillers, while too few may be getting recommended medications, a new study suggests. Researchers found that of nearly 2,900 Americans who visited the doctor for migraine relief, 15 percent were prescribed opioids such as oxycodone (OxyContin or Percocet) or hydrocodone (Norco, Vicoprofen). ...

Pot Compound Alters Levels of Seizure Drug in Epilepsy Patients

Posted 11 Aug 2017 by Drugs.com

FRIDAY, Aug. 11, 2017 – Scientists experimenting with the marijuana compound cannabidiol as an epilepsy treatment must evaluate any interactions with other anti-seizure drugs patients are taking, researchers report. The new research from the University of Alabama at Birmingham suggests cannabidiol affects blood levels of several anti-seizure drugs, especially clobazam. Cannabidiol (CBD) has ...

Number of Americans With Epilepsy at Record Level

Posted 10 Aug 2017 by Drugs.com

THURSDAY, Aug. 10, 2017 – More Americans than ever are living with epilepsy, federal health officials reported Thursday. According to the new report, 1.2 percent of the population – about 3 million adults and 470,000 children – were being treated for epilepsy or had experienced recent seizures in 2015, the researchers from the U.S. Centers for Disease Control and Prevention said. The number of ...

Seizure Control Key to Avoiding Sudden Death With Epilepsy

Posted 25 Apr 2017 by Drugs.com

TUESDAY, April 25, 2017 – In rare cases, seizures that cause convulsions and a loss of consciousness can raise the odds of sudden death in people with epilepsy, neurologists warn. These attacks are known as generalized tonic-clonic seizures, according to a new guideline from the American Academy of Neurology (AAN) and the American Epilepsy Society. Just how rare is sudden death linked to these ...

Study Sheds Light on Safety of Driving With Epilepsy

Posted 5 Dec 2016 by Drugs.com

SUNDAY, Dec. 4, 2016 – People with epilepsy who experienced longer seizures during a simulated driving test may face an increased risk for crashes while on the road, a new study suggests. About 75 percent of people with epilepsy use medication to control their seizures and are able to drive. The remainder of patients typically keep a journal of seizures, noting how long they last, and doctors ...

Study Questions Use of Migraine Meds in Kids, Teens

Posted 28 Oct 2016 by Drugs.com

THURSDAY, Oct. 27, 2016 – A new study raises questions about the effectiveness of medicines commonly prescribed to prevent migraines in children and teens. The 24-week clinical trial involving 328 patients found no significant differences between the drugs amitriptyline (Elavil), topiramate (Topamax) and a placebo sugar pill in reducing the number of days with a migraine or migraine-related ...

Newer Epilepsy Drugs May Be Safer During Pregnancy

Posted 1 Sep 2016 by Drugs.com

THURSDAY, Sept. 1, 2016 – Women who take the new epilepsy drugs levetiracetam and topiramate during pregnancy don't run the risk of harming their infant's mental development, British researchers report. But the commonly prescribed anti-seizure drug valproate was linked with lower IQs in children, especially when taken at higher doses, researchers say. "The treatment of epilepsy in women who are ...

Girls Given Risky Meds Don't Get Contraceptive Advice

Posted 16 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 16, 2015 – New research from a Midwestern hospital suggests a wide majority of teen girls and young women fail to get information about contraceptives when they take medications that could cause birth defects. At issue are so-called "teratogenic" medications, used for conditions ranging from acne to anxiety, that boost the risk of birth defects when taken during pregnancy. ...

Surgery May Help Teens With Frequent Migraines, Study Contends

Posted 25 Jun 2015 by Drugs.com

THURSDAY, June 25, 2015 – Migraine surgery may be an effective choice for teens who haven't gotten relief from standard treatment, a small study suggests. In the study, researchers at Case Western Reserve University School of Medicine in Cleveland reviewed the medical records of 14 patients, with an average age of 16. In teens with migraine who haven't responded well to other treatments, ...

FDA Approves Expanded Indication for Qudexy XR (Topiramate) for Pediatric Patients

Posted 3 Jun 2015 by Drugs.com

Maple Grove, MN – June 1, 2015 – Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that it has received U.S. Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary gen ...

Migraine Drug May Up Risk of Eating Disorders in Some Teens

Posted 9 Apr 2015 by Drugs.com

THURSDAY, April 9, 2015 – A new report has linked a migraine medication to increased odds of eating disorders in some teens. The drug in question is called topiramate (Topamax). It's an established migraine drug for adults that was just approved for use in teens in 2014. Appetite reduction and weight loss are common side effects of the drug, according to the report authors. "For most kids, it's ...

Topamax Approval for Migraines Expanded to Younger Users

Posted 31 Mar 2014 by Drugs.com

MONDAY, March 31, 2014 – U.S. Food and Drug Administration approval of the drug Topamax (topiramate) to prevent migraine headaches has been expanded to include adolescents 12 years to 17 years, the agency said Friday. It's the first migraine-prevention drug approved for adolescents, the FDA said in a news release. Topamax was first sanctioned in 1996 to prevent seizures, and was approved to ...

FDA Approves Topamax for Migraine Prevention in Adolescents

Posted 28 Mar 2014 by Drugs.com

March 28, 2014 – Today, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17. This is the first FDA approval of a drug for migraine prevention in this age group. The medication is taken on a daily basis to reduce the frequency of migraine headaches. Topamax was first approved by the FDA in 1996 to ...

Upsher-Smith Receives FDA Approval for Qudexy XR (topiramate) Extended-Release Capsules

Posted 13 Mar 2014 by Drugs.com

Maple Grove, MN – March 12, 2014 – Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced it received approval on March 11, 2014 from the U.S. Food and Drug Administration (FDA) for Qudexy XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile. Qudexy XR is indicated as initial mo ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Migraine Prevention, Migraine Prophylaxis, Fibromyalgia, Seizures, Seizure Prevention, Seizure Prophylaxis, Bipolar Disorder, Diabetic Neuropathy, Diabetic Nerve Damage, view more... Borderline Personality Disorder, Bulimia, Lennox-Gastaut Syndrome, Obesity, Smoking Cessation, Tourette's Syndrome, Trigeminal Neuralgia, Vulvodynia

Related Drug Support Groups

Topamax, Trokendi XR, Qudexy XR, Topamax Sprinkle, Topiragen

Topiramate Patient Information at Drugs.com